WiSys Technologies

13 WiSys Technologies in "Engineering" or "Pharmaceuticals & Vitamin D"

Photochemical Preparation of Fluorinated Aryl Ethers for Agrochemicals and Pharmaceuticals

WiSys is seeking a strategic partner in the agrochemical industry who can provide a route to market for the commercialization, scale-up, and use of this novel method for synthesis of aryl fluorinated ethers for pharmaceuticals and agrochemicals.

Additive-Free Method of Zinc Electrodeposition

WiSys is seeking a strategic partner in the metal plating industry who can provide a route to market for the commercialization, scale-up, and use of this additive-free method for zinc electrodeposition.

Retrofit Peltier Cooling Device

WiSys is seeking a strategic partner skilled in the manufacturing and distribution of insulated storage containers or portable mini refrigerators.  Ideally, this partner could provide a route to market for the commercialization and use of this retrofit Peltier cooling device.

Anodizing Pen

WiSys is seeking a strategic partner skilled in the processes of metal treating and finishing who could provide a route to market for the commercialization and use of this anodizing pen. 

Semiconductor Quantum Dot Computer Aided Engineering (CAE) Simulation Tool

WiSys is seeking a strategic partner skilled in the design, modeling, and fabrication of Quantum Dots and Quantum wires.  There is interest in working with a partner to test the beta version of the CAE simulation tool and provide feedback when modeling both Quantum Wires and Quantum Dots.  Additionally, there is interest in identifying a partner with a 3D finite element method solver for further development and testing of the CAE simulation tool.

Health Monitoring and Imaging System for Concrete Structures

WiSys is currently seeking strategic partners operating in the non-destructive testing industry interested in further developing this novel health monitoring system for concrete structures, ultimately providing a route to market for its commercialization.

Skin Whitening Agent(s)

WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.

Benzodiazepine Derivatives with Reduced Side Effects

The WiSys Technology Foundation is seeking commercial partners interested in developing anxiolytic and anticonvulsant benzodiazepines that offer little or no side effects.